SMPD1 and Parkinson disease: Levels of acid sphingomyelinase (ASM), which is also a risk factor for PD31, decreased in the IPD group in the OCC and in the PD-GBA group in the MTG, but was elevated in the CG in the PD-GBA group (confirmed by targeted proteomics; Supplementary Fig. 11).